Human-centered design of clinical AI to support the diagnosis of pediatric suprasellar tumors
以人为本的临床人工智能设计支持小儿鞍上肿瘤的诊断
基本信息
- 批准号:10750837
- 负责人:
- 金额:$ 3.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-03 至 2026-07-02
- 项目状态:未结题
- 来源:
- 关键词:AcademiaAdamantinomatous craniopharyngiomaAddressAdoptionArtificial IntelligenceAttentionBayesian MethodBrain NeoplasmsChildhoodClassificationClinicalClinical MedicineClinical effectivenessComplexComputer softwareConsumptionDataData SetDecision MakingDevelopmentDiagnosisDiagnosticDiagnostic ErrorsEmpathyEyeFactor AnalysisFacultyGoalsHealth Care CostsHumanHuman ResourcesIndustryInstitutionInterdisciplinary StudyKnowledgeLeadLeadershipLearningMagnetic Resonance ImagingMalignant NeoplasmsMeasuresMedicalMedicineMentorsMethodsModelingOncologyOperative Surgical ProceduresOutcomePatient CarePatientsPerformancePersonsPositioning AttributeProblem SolvingProcessProviderPublishingReportingResearchResearch PersonnelResource SharingRoleScientistSelf-Help DevicesServicesSocial SciencesStressSurgical PathologySurveysSystemTechnologyTestingTherapeutic InterventionTimeTrainingTranslatingTranslationsUncertaintyVariantVisualizationWorkartificial intelligence methodcareerclinical applicationclinical decision supportclinical decision-makingcomplex datacomputer sciencecostdeep learningdeep learning modeldesignexperiencefictional workshuman centered designimprovedinformation seeking behaviormathematical abilitymultidisciplinaryneuro-oncologyneurosurgerynoninvasive diagnosisopen sourcepressureprototyperadiological imagingsatisfactionskillssuccesstooltumortumor diagnosisusability
项目摘要
PROJECT SUMMARY/ABSTRACT
Clinical decision-making in subspecialties, like pediatric neuro-oncology, is becoming increasingly data-
driven and complex. Artificial intelligence (AI) is a powerful tool that can help distill this expanding dataset to
present the clinician with the right information at the right time. AI has had little success in clinical applications
so far, but new methods (like OpenAI's DALL-E or GPT3 models) are now in the public eye, clearly demonstrating
the power of the technology generally. Effective translation of that technology into the clinical setting requires a
comprehensive understanding of the specific clinical setting, such as personnel/roles, data/technology used,
clinical goals and workflows. Human-Centered Design (HCD) is a solution framework that emphasizes the needs
of the people who perform a specific task and is well suited to facilitate the design of clinical AI. However, HCD
is challenging to execute in this space because it is difficult and expensive to assemble a team of experts that
spans clinical medicine, artificial intelligence, visualization, and social sciences. Academia and industry have
established multidisciplinary HCD/AI teams but are seeking solutions for filling interdisciplinary leadership roles
in these teams.
I previously published a deep learning model for classifying pediatric suprasellar tumors from
preoperative MRI. My model performed as well as human experts on the same dataset (86%), which was also
congruent with previous studies on human expert performance on the task. In addition, pediatric suprasellar
tumors are almost always diagnosed via surgical pathology, with roughly 8% of patients being radiographically
diagnosed. Preliminary data (Aim 2) suggests that we can improve the deep learning model performance up to
95% by incorporating a Bayesian methodology to estimate model uncertainty. Additional preliminary data (Aim
3) indicates that embedding my model into Google's What-If Tool (WIT) can help clinicians radiographically
diagnose these tumors with less perceived difficulty and greater perceived confidence. Therefore, this proposal's
central hypothesis is that explainable AI solutions can improve human experts' pediatric suprasellar tumor
radiographic diagnosis beyond the current performance levels. Moreover, using an HCD approach, Google's
What-If Tool (WIT) can be adapted into the clinician's workflow in a manner that will result in adoption of this
assistive technology. I will investigate my aims, specifically designed to provide functional knowledge in these
topics to enable me to effectively lead a multidisciplinary team of subject-matter experts in developing robust
clinical AI tools. I am guided by an expert team of mentors representing pediatric neuro-oncology, neurosurgery,
AI, visualization, and HCD. Completion of this proposal will significantly contribute to my career goal: to be a
leader in the application of HCD to develop clinical AI technology that supports pediatric neuro-oncology patient
care.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric W Prince其他文献
Linnaeus: Interpretable Deep Learning Classification of Single Cell Transcript Data
Linnaeus:单细胞转录数据的可解释深度学习分类
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
Eric W Prince;T. Hankinson - 通讯作者:
T. Hankinson
Adamantinomatous craniopharyngioma in the molecular age and the potential of targeted therapies: a review
分子时代的金刚石瘤性颅咽管瘤和靶向治疗的潜力:综述
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
Ros Whelan;Astrid C. Hengartner;Z. Folzenlogen;Eric W Prince;T. Hankinson - 通讯作者:
T. Hankinson
Eric W Prince的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}